Adherence to Adding ICS to Rescue Therapy in a Pragmatic Trial with Adults with Asthma– a Pilot Study

Rationale Using inhaled corticosteroids (ICS) concomitantly with rescue inhalers (Patient-Activated Reliever-Triggered ICS; ‘PARTICS’) reduces asthma exacerbations in efficacy trials, but has not been tested in pragmatic trials with highly-impacted asthma populations. Barriers to completing study pr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of allergy and clinical immunology 2018-02, Vol.141 (2), p.AB209-AB209
Hauptverfasser: Cardet, Juan Carlos, Busse, Paula J., Carroll, Jennifer K., Casale, Thomas B., Coyne-Beasley, Tamera, Fagan, Maureen, Forth, Victoria E., Fuhlbrigge, Anne L., Hernandez, Michelle L., Kaelber, David, Kaplan, Barbara, Lorenzi, Margarita, Madison, Suzanne, Maher, Nancy E., Majewski, Karen, Manning, Brian, McKee, Melissa D., Nazario, Sylvette, Pace, Wilson D., Pencina, Michael J., Rand, Cynthia S., Rodriguez-Louis, Jacqueline, She, Lilin, Shields, Joel, Teng, Jessica E., Wechsler, Michael E., Wisnivesky, Juan P., Yawn, Barbara P., Israel, Elliot
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Rationale Using inhaled corticosteroids (ICS) concomitantly with rescue inhalers (Patient-Activated Reliever-Triggered ICS; ‘PARTICS’) reduces asthma exacerbations in efficacy trials, but has not been tested in pragmatic trials with highly-impacted asthma populations. Barriers to completing study procedures included having difficulty with log-in access to electronic questionnaires (30%, 38% at 6, 12 weeks, respectively), remembering to use ICS and rescue inhalers together (20%), and obtaining refills (19%).
ISSN:0091-6749
1097-6825
DOI:10.1016/j.jaci.2017.12.662